Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Shiloh

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Cell|August 14, 2019
Mechanisms of Leukemia Evolution: Lessons from a Congenital SyndromeYehudit Birger, Ruth Shiloh, Shai Izraeli
Apoptosis : an International Journal on Programmed Cell Death|November 14, 2013
The DAPK family: a structure-function analysisRuth Shiloh, Shani Bialik, Adi Kimchi
Cell Cycle (Georgetown, Tex.)|May 23, 2019
Ser289 phosphorylation activates both DAPK1 and DAPK2 but in response to different intracellular signaling pathwaysRuth Shiloh, Shani Bialik, Adi Kimchi
Cell Reports|July 29, 2014
Discovering protein-protein interactions within the programmed cell death network using a protein-fragment complementation screenYuval Gilad, Ruth Shiloh, Yaara Ber, et al.
Nature Communications|May 3, 2018
Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagyRuth Shiloh, Yuval Gilad, Yaara Ber, et al.
Journal of Biomedical Informatics|August 14, 2016
A model-driven methodology for exploring complex disease comorbidities applied to autism spectrum disorder and inflammatory bowel diseaseJudith Somekh, Mor Peleg, Alal Eran, et al.
Blood|September 22, 2023
Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signalingRuth Shiloh, Ruth Lubin, Odeya David, et al.
Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.
Blood|June 25, 2024
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Ruth Shiloh, Jan L C Loeffen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell|August 14, 2019
Mechanisms of Leukemia Evolution: Lessons from a Congenital SyndromeYehudit Birger, Ruth Shiloh, Shai Izraeli
Apoptosis : an International Journal on Programmed Cell Death|November 14, 2013
The DAPK family: a structure-function analysisRuth Shiloh, Shani Bialik, Adi Kimchi
Cell Cycle (Georgetown, Tex.)|May 23, 2019
Ser289 phosphorylation activates both DAPK1 and DAPK2 but in response to different intracellular signaling pathwaysRuth Shiloh, Shani Bialik, Adi Kimchi
Cell Reports|July 29, 2014
Discovering protein-protein interactions within the programmed cell death network using a protein-fragment complementation screenYuval Gilad, Ruth Shiloh, Yaara Ber, et al.
Nature Communications|May 3, 2018
Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagyRuth Shiloh, Yuval Gilad, Yaara Ber, et al.
Journal of Biomedical Informatics|August 14, 2016
A model-driven methodology for exploring complex disease comorbidities applied to autism spectrum disorder and inflammatory bowel diseaseJudith Somekh, Mor Peleg, Alal Eran, et al.
Blood|September 22, 2023
Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signalingRuth Shiloh, Ruth Lubin, Odeya David, et al.
Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.
Blood|June 25, 2024
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignanciesSarah Elitzur, Ruth Shiloh, Jan L C Loeffen, et al.
Pageof 1